drugset / Trial / NCT00192673

Poly(Ethylene Glycol)(PEG)-Asparaginase During Two Treatment Courses

NCT00192673

Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is 1. to determine the correct dose for intramuscular administration 2. to compare the frequency of antibody formation after intramuscular administration of native E.coli asparaginase and PEG-asparaginase during two treatment courses in the treatment of childhood lymphoblastic leukemia

Timeline

Start
2005-06
Primary completion
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Pegaspargase Protein / enzyme biologic Intramuscular